Bussiness Ideas

Myotech V-HAB is a health-tech startup by AIIMS Delhi Alumini which aims at developing health care devices (diagnostic and therapeutic). V-HAB is a health-tech device which aims at curing the problem of progressive myopia (i.e. frequent increase in the refractive power of eyes in age group of 5-21) for which there is no permanent cure in the industry. The only temporary solution is spectacles and Contact lens but they also have their complications and side effect like hygiene issues and comfort issues and the refractive power of the eyes increases till a very high power to do daily activities and it becomes cumbersome for a child to use thick glasses. Also the child has to change the spectacles after every 3 to 4 months because of increase in refractive power of eyes that takes a toll on their physical mental social and academic development of the child also on the financial status of the family. Acc. To WHO, the current prevalence of myopia is 26% and till 2050 it will increase exponentially up to 50% that is one out of every two person will be myopic.So the demand is very high and it will be the breakthrough in the healthcare industry with our USPs. Our startup also targets the problem of digital eye strain, myopic strain dry eye. As almost half of the population ( prevalence 58%) is on screen from morning till evening due to various reasons, they face heavy strain on their eyes for which there is no cure. Our therapy is the first and foremost permanent solution which is highly effective (87% minimum), with zero side effects, non-invasive, personalised and customised device even comfortable for 3 year old child. V-HAB is the therapeutic health-tech device based on RLRLT therapy which will be B2B collaborating with hospitals and clinics and B2C end to end from our website assisted entirely by our team and on subscription based model. It will be B2B and B2C. We will collaborate with hospitals and clinics, Ophthalmologists and Optometrist. They will prescribe our therapy and device to the patients coming to them with the progressive myopia and digital eye strain and our team will guide them on the usage and duration of the therapy (eg. 3 months for 5 minutes twice a day) according to the eye specifications, sign and symptoms as well as refractive power of eyes further. It will be on a subscription based model for a period of 3-6 months for progressive myopia. The device will also be available on our website for direct purchase and as soon as the customer will purchase the device, our team of professionals will directly connect with them for the process of use, duration, timing and any other assistance needed. It will be an end-to-end solution. Our team will be in direct contact with the customers as long as the therapy will be in process. It will be a therapy for 3-6 months for progressive myopia and for digital eye strain and dry eyes, the customers can directly purchase for lifetime. Our USPs are- Highest efficiency possible (minimum 87% max 98% ) No side effects, safe Completely non-invasive Comfortable and handy for even a 3 year old child Customised designs Personalised assistance For myopia -our target customer is children of age group of 5-21 years. For digital eye strain and dry eyes- we are targeting teenagers, youth and even old age people working on screens. So, we have our customers in every strata of age. Our Mission is to cure progressive myopia, digital eye strain, dry eyes and other eye diseases. And also to prevent sight threatening diseases in the later stage of life which above diseases lead to, after 45 years of age causing complete loss of vision. Our Vision is to develop A device for every eye and A device for every age.